wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q26747768-2FBB50B2-8552-4AA2-B16A-EBF2D57CEF3B
Q26747768-2FBB50B2-8552-4AA2-B16A-EBF2D57CEF3B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26747768-2FBB50B2-8552-4AA2-B16A-EBF2D57CEF3B
Clinical developments in the treatment of relapsed or relapsed and refractory multiple myeloma: impact of panobinostat, the first-in-class histone deacetylase inhibitor
P2860
Q26747768-2FBB50B2-8552-4AA2-B16A-EBF2D57CEF3B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26747768-2FBB50B2-8552-4AA2-B16A-EBF2D57CEF3B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c19fc355a711570214b2a192e0d8cf2a0eae1518
P2860
Histone deacetylase inhibitor panobinostat induces clinical responses with associated alterations in gene expression profiles in cutaneous T-cell lymphoma.